Nom du produit:N-hydroxy-4-(4-methyl-5-(2-(trifluoromethyl)phenyl)-4H-1,2,4-triazol-3-yl)bicyclo[2.2.2]octane-1-carboximidamide
IUPAC Name:N-hydroxy-4-{4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}bicyclo[2.2.2]octane-1-carboximidamide
- CAS:935273-85-1
- Formule moléculaire:C19H22F3N5O
- Pureté:95%
- Numéro de catalogue:CM201595
- Poids moléculaire:393.41
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:935273-85-1
- Formule moléculaire:C19H22F3N5O
- Point de fusion:-
- Code SMILES:N=C(C1(CC2)CCC2(C3=NN=C(C4=CC=CC=C4C(F)(F)F)N3C)CC1)NO
- Densité:
- Numéro de catalogue:CM201595
- Poids moléculaire:393.41
- Point d'ébullition:
- N° Mdl:
- Stockage:Store at 2-8°C.
Category Infos
- Bridged Compounds
- Bridged ring compound refers to any two rings in the compound, which share two non-directly connected carbon atoms, and are classified into bicyclic hydrocarbons, tricyclic hydrocarbons, tetracyclic hydrocarbons, etc. Carbon atoms used in two or more rings are bridgehead carbon atoms, and the bond connecting the bridgehead carbon atoms is called a bridge. Bridged ring compounds are a class of organic compounds that are widely present in nature and usually have important physiological activities, such as the famous anticancer drug paclitaxel and antimalarial drug artemisinin.
- bridged compounds,bridged bicyclic compounds
- Buy low price, high quality bridged compounds and bridged bicyclic compounds,choose our products,Chemenu is the leading factory & company. Warmly welcome new and old customers to visit and patronize!
- Triazoles
- Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.